HDAC9 and epilepsy: Epigenetics, the process by which gene activity is altered without alterations in the DNA sequence, is thought to contribute to epilepsy and epileptogenesis, and HDAC inhibitors like VPA are currently used in therapy with significant results in terms of neuroprotection (Citraro et al., 2018; Romoli et al., 2019).